Minnesota Healthsolutions Corporation

Minnesota Healthsolutions Corporation, a woman-owned small business based in Minneapolis, Minnesota, develops medical devices and digital health platforms for the federal government as a prime grant recipient, with 95% of its federal footprint in NIH grants focused on device innovation and patient engagement applications. The company operates as a Subchapter S corporation and competes predominantly under WOSB designation across its NIH customer base.

Minnesota Healthsolutions' customer concentration is highly concentrated within the National Institutes of Health. The top five funding entities account for 71% of all awards, led by the National Heart, Lung, and Blood Institute (13 awards) and the National Institute of Child Health and Human Development (13 awards), followed by the National Institute on Aging (8 awards), the Centers for Disease Control and Prevention (6 awards), and the broader National Institutes of Health (6 awards). Across 65 total awards dating to 2007, the company has obligated $76.5 million in combined federal funding, with seventeen distinct customer agencies served.

Minnesota Healthsolutions' capability portfolio spans two distinct tracks: implantable and interventional medical device development, and behavioral and digital health applications. On the device side, the company has received $329,537 from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) for a Phase I Small Business Innovation Research project to develop a novel balloon angioplasty inflation device accounting for molecular composition and elasticity differences in arterial tissue (award date August 15, 2026, ultimate completion August 14, 2027); $1,068,096 from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to prototype a novel bladder catheterization device for neurogenic bladder management (awarded September 15, 2025, completion August 31, 2027); and $628,558 from the same institute for an innovative dialysis cannulation needle designed to reduce infiltration injury during hemodialysis (awarded September 12, 2025, completion August 31, 2027). On the digital health and behavioral intervention side, Minnesota Healthsolutions received $353,306 from the National Institute of Mental Health (CFDA 93.242) to develop a mobile app supporting parents of teenagers with ADHD during the learning-to-drive period (awarded July 6, 2026, completion June 30, 2027) and $1.068 million from the National Institute of Diabetes and Digestive and Kidney Diseases for an adaptable remote-monitoring and health-coaching platform supporting behavior change for multiple chronic conditions in collaboration with Mayo Clinic (awarded September 15, 2023, completion September 14, 2025). The company has also developed a dynamic headrest system for child safety seats to reduce head injuries in side-impact crashes under the National Institute of Child Health and Human Development (awarded June 20, 2025, completion June 19, 2027) and telematics-based driving coach applications for older adults with cognitive impairment and for autistic teens learning to drive, both funded by the National Institute on Aging and the National Institute of Child Health and Human Development respectively.

Activity has remained flat year over year—four awards each in 2022 and 2023, four in 2024, five in 2025, and two in 2026 to date. Five awards carry ultimate completion dates within the next twenty-four months and therefore face recompete exposure. The vendor acts as a sub-recipient on a small number of grants, including a sub-award with Mayo Clinic Arizona for pulmonary rehabilitation for rural patients with COPD (awarded September 15, 2025), with Applied Universal Dynamics Corp for 3D printing technology development services (awarded February 1, 2025), and with the University of Alabama at Birmingham for an evidence-based tool supporting independence for autistic individuals (awarded October 30, 2024). Minnesota Healthsolutions' federal grant portfolio is exclusively SBIR or cooperative-agreement funded, with no federal contracts, GWACs, or agency-wide IDIQs in the source data.